These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29109771)

  • 1. Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy.
    Cureton N; Korotkova I; Baker B; Greenwood S; Wareing M; Kotamraju VR; Teesalu T; Cellesi F; Tirelli N; Ruoslahti E; Aplin JD; Harris LK
    Theranostics; 2017; 7(15):3715-3731. PubMed ID: 29109771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype.
    Kusinski LC; Stanley JL; Dilworth MR; Hirt CJ; Andersson IJ; Renshall LJ; Baker BC; Baker PN; Sibley CP; Wareing M; Glazier JD
    Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R86-93. PubMed ID: 22552791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice.
    Kulandavelu S; Whiteley KJ; Qu D; Mu J; Bainbridge SA; Adamson SL
    Hypertension; 2012 Jul; 60(1):231-8. PubMed ID: 22615111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction.
    Stanley JL; Andersson IJ; Hirt CJ; Moore L; Dilworth MR; Chade AR; Sibley CP; Davidge ST; Baker PN
    Biol Reprod; 2012 Jul; 87(1):25, 1-8. PubMed ID: 22423051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction.
    Thaete LG; Kushner DM; Dewey ER; Neerhof MG
    Placenta; 2005; 26(2-3):242-50. PubMed ID: 15708126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific increases in utero- and fetoplacental arterial vascular resistance in eNOS-deficient mice due to impaired arterial enlargement.
    Rennie MY; Rahman A; Whiteley KJ; Sled JG; Adamson SL
    Biol Reprod; 2015 Feb; 92(2):48. PubMed ID: 25519187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of resveratrol in pregnancy using murine models with reduced blood supply to the uterus.
    Poudel R; Stanley JL; Rueda-Clausen CF; Andersson IJ; Sibley CP; Davidge ST; Baker PN
    PLoS One; 2013; 8(5):e64401. PubMed ID: 23667712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP-activated protein kinase activator AICAR attenuates hypoxia-induced murine fetal growth restriction in part by improving uterine artery blood flow.
    Lane SL; Houck JA; Doyle AS; Bales ES; Lorca RA; Julian CG; Moore LG
    J Physiol; 2020 Sep; 598(18):4093-4105. PubMed ID: 32592403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Technologies for Target Delivery of Therapeutics to the Placenta during Pregnancy: A Review.
    Pepe GJ; Albrecht ED
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a human IGF-II analog ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction.
    Charnock JC; Dilworth MR; Aplin JD; Sibley CP; Westwood M; Crocker IP
    Am J Physiol Endocrinol Metab; 2016 Jan; 310(1):E24-31. PubMed ID: 26530156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sildenafil citrate treatment in the eNOS knockout mouse model of fetal growth restriction on long-term cardiometabolic outcomes in male offspring.
    Mills V; Plows JF; Zhao H; Oyston C; Vickers MH; Baker PN; Stanley JL
    Pharmacol Res; 2018 Nov; 137():122-134. PubMed ID: 30292428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal Growth Restriction Induced by Transient Uterine Ischemia-Reperfusion: Differential Responses in Different Mouse Strains.
    Thaete LG; Qu XW; Neerhof MG; Hirsch E; Jilling T
    Reprod Sci; 2018 Jul; 25(7):1083-1092. PubMed ID: 28946817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
    Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of mouse uterine and fetoplacental vascular function.
    Kusinski LC; Baker PN; Sibley CP; Wareing M
    Reprod Sci; 2009 Aug; 16(8):740-8. PubMed ID: 19443912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
    Groten T; Lehmann T; Städtler M; Komar M; Winkler JL; Condic M; Strizek B; Seeger S; Jäger Y; Pecks U; Eckmann-Scholz C; Kagan KO; Hoopmann M; von Kaisenberg CS; Brodowski L; Tauscher A; Schrey-Petersen S; Friebe-Hoffmann U; Lato K; Hübener C; Delius M; Verlohren S; Sroka D; Schlembach D; de Vries L; Kraft K; Seliger G; Schleußner E;
    Am J Obstet Gynecol; 2023 Jan; 228(1):84.e1-84.e12. PubMed ID: 35931132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental bed research: II. Functional and immunological investigations of the placental bed.
    Harris LK; Benagiano M; D'Elios MM; Brosens I; Benagiano G
    Am J Obstet Gynecol; 2019 Nov; 221(5):457-469. PubMed ID: 31288009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype.
    Dilworth MR; Andersson I; Renshall LJ; Cowley E; Baker P; Greenwood S; Sibley CP; Wareing M
    PLoS One; 2013; 8(10):e77748. PubMed ID: 24204949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.